Summary
Updated Aug 30, 2026
John A. Josey files SEC Form 4 reports at Day One Biopharmaceuticals, Inc. (DAWN). 2 SEC Form 4 filings on record going back to 2025, most recently on 23 April 2026.
Recent Transactions
1Every recent SEC Form 4 transaction John A. Josey has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies John A. Josey files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jeremy Bender - $321K of DAWN open-market activity in the last 12 months
- Adam Dubow - $113K of DAWN open-market activity in the last 12 months
- Charles N. York II - $107K of DAWN open-market activity in the last 12 months
- Lauren Merendino - $101K of DAWN open-market activity in the last 12 months
- Michael Vasconcelles - $32K of DAWN open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is John A. Josey?
John A. Josey is a corporate insider of Day One Biopharmaceuticals, Inc. (DAWN). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did John A. Josey last file a Form 4?
The most recent primary Form 4 on record is dated 23 April 2026, one of 2 filings going back to 2025.
Where can I see all of John A. Josey's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow John A. Josey and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
